SOD2 and diabetic retinopathy: Studies have shown that the manganese superoxide dismutase (MnSOD) mimetic MnTBAP effectively prevented mitochondrial damage by reducing DNMT1 binding to the MMP-9 promoter (Kowluru and Shan, 2017), suggesting that targeting DNA methylation to inhibit MMP-9 could suppress oxidative stress and serve as a promising therapeutic strategy for diabetic retinopathy.